Skip to main content

Patient Registry Software Market Set to Soar Past USD 4.93 Billion by 2030 | Skyquest Technology

The Patient Registry Software market, poised for substantial growth (2023-2030), offers versatile deployment options (on-premise and cloud-based). It encompasses various registry types, including disease, product, and health service registries. Catering to diverse end users such as hospitals, research centers, pharmaceutical companies, government organizations, and more, it presents a dynamic landscape for healthcare technology.

Westford, USA, Jan. 30, 2024 (GLOBE NEWSWIRE) — The global Patient Registry Software market size is expected to reach USD 4.93 billion by 2030 and exhibit a CAGR of 15% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing demand for real-time patient data and healthcare analytics, the need for disease surveillance and outbreak management, the focus on patient-centric care and outcome-based healthcare, regulatory requirements for data reporting and interoperability, and the growing prevalence of chronic diseases are fueling the market’s growth.

According to SkyQuest’s latest global research of the Patient Registry Software market, the increasing use of artificial intelligence and machine learning for data analysis and predictive analytics, the expansion of disease-specific and rare disease registries, the emphasis on interoperability and data exchange with other healthcare systems, the adoption of cloud-based and mobile solutions for remote data collection and access, and the integration of patient-reported outcomes for a holistic view of patient health are the trends that aid in the market’s growth.

Get a sample copy of this report:

https://www.skyquestt.com/sample-request/patient-registry-software-market

Browse in-depth TOC on “Patient Registry Software Market”

  • Pages – 157
  • Tables – 91
  • Figures -76

Patient registry software is a software application that is used to collect, store, and manage data about patients with a particular disease or condition.

Prominent Players in the Patient Registry Software Market

  • ArborMetrix Inc.
  • IQVIA Holdings Inc.
  • OpenText Corporation
  • Optum
  • Premier, Inc.
  • FIGmd
  • McKesson Corporation
  • Syneos Health
  • Dacima Software
  • ifa Systems AG
  • Medstreaming- M2S
  • ImageTrend
  • Evado Clinical
  • WIRB Copernicus Group
  • Global Vision Technologies
  • Conduent, Inc.
  • Elekta AB
  • Cedaron
  • Lumdex
  • Armus
  • Phamax AG
  • Versaform Systems Corp
  • ESO Solutions
  • Ordinal Data Inc.

Report Scope & Segmentation:

Attributes

 

Details

 

Forecast Period

 

2023-2030
Market Size in 2022

 

 1.61 Billion
2030 Value Projection

 

4.93 Billion
CAGR 15%
Segments Covered

 

 

 

 

  • Deployment Mode

on-premise and cloud-based solutions

  • Type

disease registries, product registries, health service registries, and others

  • End User

hospitals, research centers, pharmaceutical companies, government organizations, and others

 

 

 

Regions Covered

 

 

North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)

Disease Registries Demand to Grow Substantially in the Forecast Period

Disease registries dominate the global online market as they are central to healthcare management, especially in addressing the increasing prevalence of chronic diseases and rare conditions. They play a crucial role in tracking disease patterns, outcomes, and patient populations.

Browse summary of the report and Complete Table of Contents (ToC):

https://www.skyquestt.com/report/patient-registry-software-market

Population Health Analytics is the Leading Application Segment

In terms of application, Population Health Analytics is the leading segment as they are crucial for healthcare providers transitioning from fee-for-service to value-based care models. This approach prioritizes the health outcomes of an entire population, emphasizing prevention and proactive healthcare management.

North America is the leading Market Due to the Technological Advancements

Region-wise, North America is one of the largest growing markets due to the advanced healthcare infrastructure, a large number of healthcare organizations, research institutions, and technology companies. The emphasis on electronic health records (EHRs), regulatory requirements, and the adoption of advanced healthcare IT solutions contributed to North America’s market presence.

A recent report thoroughly analyzes the major players operating within the Patient Registry Software market. This comprehensive evaluation has considered several crucial factors, such as collaborations, mergers, innovative business policies, and strategies, providing invaluable insights into the key trends and breakthroughs in the market. Additionally, the report has carefully scrutinized the market share of the top segments and presented a detailed geographic analysis. Finally, the report has highlighted the major players in the industry and their ongoing endeavours to develop innovative solutions that cater to the ever-increasing demand for Patient Registry Software.

Key Developments in the Patient Registry Software Market

  • Quantori, LLC introduced a new initiative called the Registry Science Practice, with a specific focus on developing registry programs for patients, clinicians, and researchers. The aim of this practice is to create comprehensive registry programs that facilitate the collection and analysis of data to support healthcare outcomes.

Speak to Analyst for your custom requirements:

https://www.skyquestt.com/speak-with-analyst/patient-registry-software-market

Key Questions Answered in Patient Registry Software Market Report

  • What specific growth drivers will impact the market during the forecast period?
  • Can you list the top companies in the market and explain how they have achieved their positions of influence?
  • In what ways do regional trends and patterns differ within the global market, and how might these differences shape the market’s future growth?

Related Reports in SkyQuest’s Library:

Global Allergic Rhinitis Market

Global Coagulation Testing Market

Global Bleeding Disorders Treatment Market

Global Orthopedic Prosthetics Market

U.S. Speech Therapy Market

About Us:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.

Address:

1 Apache Way, Westford, Massachusetts 01886

Phone:

USA (+1) 617-230-0741

Email: sales@skyquestt.com

LinkedIn Facebook Twitter

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.